Related Experiment Video
Updated: Oct 25, 2025

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Specific White Matter Tracts and Diffusion Properties Predict Conversion From Mild Cognitive Impairment to
David B Stone1,2, Sephira G Ryman1,2, Alexandra P Hartman1,2
1AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd., and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics.
Researchers identified specific white matter tracts using diffusion tensor imaging (DTI) that predict Alzheimer's Disease (AD) risk in mild cognitive impairment (MCI) patients. These brain imaging biomarkers show promise for early AD detection.
Area of Science:
- Neuroimaging
- Biomarkers
- Neurodegenerative Diseases
Background:
- Identifying reliable biomarkers for Alzheimer's Disease (AD) risk assessment is crucial.
- Mild cognitive impairment (MCI) is a prodromal stage for AD, necessitating early detection strategies.
Purpose of the Study:
- To investigate white matter integrity in MCI patients who converted to AD versus those who remained stable.
- To identify specific white matter tracts and diffusion measures predictive of MCI to AD conversion.
Main Methods:
- Diffusion tensor imaging (DTI) and automated fiber quantification were used on 34 MCI-to-AD converters and 53 stable MCI patients.
- Support vector machines (SVMs) analyzed diffusion properties of 20 major white matter tracts to classify conversion risk.
Main Results:
- Diffusivity measures from seven white matter tracts predicted AD conversion, with axial diffusivity being the most significant.
- Specific regions within the right cingulate hippocampal bundle, right inferior frontal occipital fasciculus, and left inferior longitudinal fasciculus were key predictors.
- An SVM model utilizing these regions achieved 75% accuracy in predicting MCI to AD conversion.
Conclusions:
- White matter integrity changes, particularly in specific tracts, serve as potential biomarkers for AD risk in MCI.
- These DTI-based findings offer a promising avenue for early AD detection and risk stratification.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Spinal Cord: Cross-sectional Anatomy
Gray Matter and its Components
Central to the gray matter is...

